HD5 Levels in Catheter Versus Bag Urine Specimens in Young Children for the Diagnosis of UTI



Status:Recruiting
Conditions:Other Indications, Urology, Urinary Tract Infections
Therapuetic Areas:Nephrology / Urology, Other
Healthy:No
Age Range:Any
Updated:4/17/2018
Start Date:April 23, 2017
End Date:July 31, 2018
Contact:Kristy Morse, MD
Email:kmorse1@uthsc.edu
Phone:901-352-0551

Use our guide to learn which trials are right for you!

Urinary tract infections (UTIs) are a common cause of bacteremia and serious bacterial
infections in young children (2-24 months of age). Because these children are usually unable
to say what symptoms they are experiencing, UTIs are diagnosed through testing. Current
testing of urine samples require a catheter or suprapubic aspiration performed for urine
collection for infections markers to be reliable. Bag specimens often have varying results
that can be poor in sensitivity and specificity depending on what component of the urine test
one is looking at. Catheter and aspiration testing can be anxiety-provoking to parents, be
painful for patients and even introduce bacteria into the bladder. An antimicrobial peptide
called alpha human defensin-5 (HD5) is produced by the uroepithelium in response to
infection. HD5 has been studied in the urine and does increase in actual UTIs. This study
will look at children 1 to 24 months of age and again study levels of HD5 in culture positive
UTIs versus urine negative for UTI. This study will also determine if collection method
alters HD5 levels. We will measure HD5 levels in the urine from a bag specimen and a catheter
specimen in the same patient.

Our primary objective is to determine the sensitivity and specificity of HD5 measured in
urine collected by bag and catheter in the same patient for the diagnosis of UTI in children
between the age 1 to 24 months presenting with febrile illness and suspected UTI.

Pediatric urinary tract infections (UTIs) are a common diagnosis and account for greater than
500,000 emergency department (ED) visits each year in the US. Although prevalence varies by
age, gender, ethnicity and circumcision status, the overall prevalence is cited between 5% to
13.8%. UTIs also account for a large number of pediatric hospital admissions with up to
50,000 children admitted per year, 40% of which occurring in children under the age of 1
year. In children under the age of two, diagnosis of UTI is difficult as patients are unable
to verbalize complaints and often present with only fever or other nonspecific symptoms such
as vomiting. UTIs are the leading cause of occult bacteremia and serious bacterial infection
in the 2-24 month age range.

A definitive diagnosis of UTI is made when a patient has pyuria and/or bacteriuria with a
positive urine culture. For non-toilet trained children who have urine collected by either
suprapubic aspiration (SPA) or bladder catheterization, a urine culture is considered
positive if a single uropathogenic organism of at least 50,000 colony forming units (CFU) per
mL is recovered. Identification of a uropathogen by culture can take up to 48 hours to be
completed which delays treatment and risks progression of infection if antibiotics are not
given empirically. Commonly, clinicians use urine microscopy and dipstick for quick diagnosis
to enable early empiric treatment of UTIs. However, the components of the urinalysis are
limited in sensitivity and specificity even for specimens of high quality such as those
obtained by catheterization or suprapubic tap. The main components of urine dipstick testing
are leukocyte esterase (LE) and nitrite levels in urine. The LE test has a sensitivity of 94%
when combined with clinical suspicion for UTI, but a specificity of only 83%. False positives
for UTI occur when LE is positive in the child who has pyuria for other reasons besides
infection, for example, in urethritis or Kawasaki disease. False negatives can occur in young
children because the pattern of more frequent urination allows less time to mount an adequate
inflammatory response to bacteria. Nitrites have a low sensitivity in young children (53%)
due to frequent voiding not allowing sufficient time (up to 4 hours) for production of
nitrites by bladder-dwelling bacteria; however, specificity is high (98%) making this a good
test to rule in UTI. Sensitivity and specificity of urine microscopy for WBCs and bacteria
are worse than for LE with pyuria (5 or more WBC/high power field on a spun sample or >10
WBC/hpf on an un-spun sample) having a sensitivity and specificity of 73% and 81%
respectively. Presence of bacteria on microscopy has a sensitivity and specificity of 81% and
83% respectively. The resulting over- and under-treatment for false positive and negative
urinalyses leads to increased costs, antibiotic resistance and unnecessary adverse events
from antibiotics. The inaccuracy of the traditional urinalysis on bagged urine samples is
much greater than for catheter specimens. These specimens suffer from false positives results
for leukocyte esterase and cultures at rates up to 75-88% because of contamination by
urogenital flora and white blood cells present on the perineum.

As a result of the poor performance characteristics of routine urinalyses on bag specimens, a
sample obtained by catheterization in children who are not yet toilet-trained is required
even for UTI screening. This is invasive and painful for the child, causes anxiety for the
family, leads to urethral trauma and can even introduce bacteria into the urinary system.
Recent research describes a new two-step technique of obtaining urine samples of screening
for UTI on these young patients. First, a bagged urine sample is taken, and if suspicious for
UTI by urinalysis, the patient then is catheterized for culture. One study showed that this
technique decreased the number of catheterizations by 33%; however, given the low specificity
of the urinalyses on bag specimens, there is still substantial room for reductions in
unnecessary bladder catheterizations.

New urinary biomarkers hold promise to improve screening accuracy for UTIs. Watson et al.
investigated antimicrobial peptides (AMPs) as urinary biomarkers of UTIs in children. One
specific AMP, derived from the epithelium, is human alpha-defensin 5 (HD5). This AMP is
produced by intestinal Paneth cells, the female genital tract and the uroepithelium. HD5 was
found to have mean concentration significantly higher in the urine from culture-positive
compared to culture-negative specimens. When used in combination with LE, HD5 increased the
specificity of the LE-only test by 6% without decreasing the sensitivity (97% for LE >
trace). This study determined the optimal cut-off value of 174 pg/mg creatinine to declare
sample positive. Because HD5 is not derived from white blood cells, its presence is not
affected by the presence or absence of WBCs in the urine to accurately identify urinary
inflammation. While the authors of this study examined results from both clean-catch and
catheterized specimens, they did not analyze samples collected by both techniques from the
same patient.

Identification and validation of biomarkers with improved performance characteristics could
reduce over-treatment of UTIs; validating such biomarkers on bag urine specimens has the
further benefit of reducing the need for catheterization to provide urine to screen for UTI
in a relatively unselected population of young children who have fever without a focus. We
propose to compare the use of HD5 in bag versus catheter urine samples on children 1 to 24
months of age to determine if the biomarker has similarly high sensitivity and specificity to
the original study in both specimen types. Eliminating the need for urine culture would also
save on costs for children whose rapid testing does not suggest UTI. Reducing the number of
catheterizations performed on young children will decrease the number of painful procedures,
prevent introduction of bacteria in the urinary tract and decrease parental anxiety.

Inclusion Criteria:

Patient is between 1 to 24 months of age Patient has reported or measured fever >38.5
degrees C (101.3 degrees F)

Exclusion Criteria:

RSV Positive at time of urine collection Flu Positive at time of urine collection Known GU
abnormality Neurogenic bladder Frequent catheterizations Indwelling catheter Antibiotics in
the last 7 days
We found this trial at
1
site
Memphis, Tennessee 38105
Phone: 901-352-0551
?
mi
from
Memphis, TN
Click here to add this to my saved trials